These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1523 related items for PubMed ID: 9443413

  • 1. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC, Chen CY, Chen SK, Cherng SH, Ho WL, Lee H.
    Cancer Res; 1998 Jan 15; 58(2):328-33. PubMed ID: 9443413
    [Abstract] [Full Text] [Related]

  • 2. High frequency of frameshift mutation on p53 gene in Taiwanese with non small cell lung cancer.
    Chang MY, Chong IW, Chen FM, Wang JY, Cheng TL, Cheng YJ, Sheu CC, Hung SY, Yang MC, Lin SR.
    Cancer Lett; 2005 May 26; 222(2):195-204. PubMed ID: 15863268
    [Abstract] [Full Text] [Related]

  • 3. p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomas.
    Hashimoto T, Tokuchi Y, Hayashi M, Kobayashi Y, Nishida K, Hayashi S, Ishikawa Y, Tsuchiya S, Nakagawa K, Hayashi J, Tsuchiya E.
    Cancer Res; 1999 Nov 01; 59(21):5572-7. PubMed ID: 10554037
    [Abstract] [Full Text] [Related]

  • 4. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis.
    Kawasaki H, Ogura T, Yokose T, Nagai K, Nishiwaki Y, Esumi H.
    Hum Pathol; 2001 Oct 01; 32(10):1043-9. PubMed ID: 11679937
    [Abstract] [Full Text] [Related]

  • 5. Mechanism of inactivation of CDKN2 and MTS2 in non-small cell lung cancer and association with advanced stage.
    Nakagawa K, Conrad NK, Williams JP, Johnson BE, Kelley MJ.
    Oncogene; 1995 Nov 02; 11(9):1843-51. PubMed ID: 7478613
    [Abstract] [Full Text] [Related]

  • 6. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women.
    Gealy R, Zhang L, Siegfried JM, Luketich JD, Keohavong P.
    Cancer Epidemiol Biomarkers Prev; 1999 Apr 02; 8(4 Pt 1):297-302. PubMed ID: 10207632
    [Abstract] [Full Text] [Related]

  • 7. TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis.
    de Anta JM, Jassem E, Rosell R, Martínez-Roca M, Jassem J, Martínez-López E, Monzó M, Sánchez-Hernández JJ, Moreno I, Sánchez-Céspedes M.
    Oncogene; 1997 Dec 11; 15(24):2951-8. PubMed ID: 9416838
    [Abstract] [Full Text] [Related]

  • 8. Mutations in exon 7 and 8 of p53 as poor prognostic factors in patients with non-small cell lung cancer.
    Huang C, Taki T, Adachi M, Konishi T, Higashiyama M, Miyake M.
    Oncogene; 1998 May 14; 16(19):2469-77. PubMed ID: 9627113
    [Abstract] [Full Text] [Related]

  • 9. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
    Gao H, Wang LD, Zhou Q, Hong JY, Huang TY, Yang CS.
    Cancer Res; 1994 Aug 15; 54(16):4342-6. PubMed ID: 8044781
    [Abstract] [Full Text] [Related]

  • 10. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group.
    Chiba I, Takahashi T, Nau MM, D'Amico D, Curiel DT, Mitsudomi T, Buchhagen DL, Carbone D, Piantadosi S, Koga H.
    Oncogene; 1990 Oct 15; 5(10):1603-10. PubMed ID: 1979160
    [Abstract] [Full Text] [Related]

  • 11. Use of the single strand conformation polymorphism technique and PCR to detect p53 gene mutations in small cell lung cancer.
    Hensel CH, Xiang RH, Sakaguchi AY, Naylor SL.
    Oncogene; 1991 Jun 15; 6(6):1067-71. PubMed ID: 1648702
    [Abstract] [Full Text] [Related]

  • 12. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
    Irie K, Ishida H, Furukawa T, Koyanagi K, Miyamoto Y.
    Rinsho Byori; 1996 Jan 15; 44(1):32-41. PubMed ID: 8691638
    [Abstract] [Full Text] [Related]

  • 13. p53 mutations in defined structural and functional domains are related to poor clinical outcome in non-small cell lung cancer patients.
    Skaug V, Ryberg D, Kure EH, Arab MO, Stangeland L, Myking AO, Haugen A.
    Clin Cancer Res; 2000 Mar 15; 6(3):1031-7. PubMed ID: 10741731
    [Abstract] [Full Text] [Related]

  • 14. Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas.
    Wagata T, Shibagaki I, Imamura M, Shimada Y, Toguchida J, Yandell DW, Ikenaga M, Tobe T, Ishizaki K.
    Cancer Res; 1993 Feb 15; 53(4):846-50. PubMed ID: 8094033
    [Abstract] [Full Text] [Related]

  • 15. Distinct mutational spectrum of the p53 gene in lung cancers from Chinese women in Hong Kong.
    Takagi Y, Koo LC, Osada H, Ueda R, Kyaw K, Ma CC, Suyama M, Saji S, Takahashi T, Tominaga S.
    Cancer Res; 1995 Nov 15; 55(22):5354-7. PubMed ID: 7585600
    [Abstract] [Full Text] [Related]

  • 16. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
    Tam AS, Foley JF, Devereux TR, Maronpot RR, Massey TE.
    Cancer Res; 1999 Aug 01; 59(15):3634-40. PubMed ID: 10446974
    [Abstract] [Full Text] [Related]

  • 17. Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma.
    Tomizawa Y, Kohno T, Fujita T, Kiyama M, Saito R, Noguchi M, Matsuno Y, Hirohashi S, Yamaguchi N, Nakajima T, Yokota J.
    Oncogene; 1999 Jan 28; 18(4):1007-14. PubMed ID: 10023676
    [Abstract] [Full Text] [Related]

  • 18. Reduced transcription of the RB2/p130 gene in human lung cancer.
    Xue Jun H, Gemma A, Hosoya Y, Matsuda K, Nara M, Hosomi Y, Okano T, Kurimoto F, Seike M, Takenaka K, Yoshimura A, Toyota M, Kudoh S.
    Mol Carcinog; 2003 Nov 28; 38(3):124-9. PubMed ID: 14587097
    [Abstract] [Full Text] [Related]

  • 19. Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics.
    Gorgoulis VG, Zacharatos P, Mariatos G, Liloglou T, Kokotas S, Kastrinakis N, Kotsinas A, Athanasiou A, Foukas P, Zoumpourlis V, Kletsas D, Ikonomopoulos J, Asimacopoulos PJ, Kittas C, Field JK.
    Cancer Res; 2001 Jan 15; 61(2):538-49. PubMed ID: 11212247
    [Abstract] [Full Text] [Related]

  • 20. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
    Okano T, Gemma A, Hosoya Y, Hosomi Y, Nara M, Kokubo Y, Yoshimura A, Shibuya M, Nagashima M, Harris CC, Kudoh S.
    Oncol Rep; 2006 Mar 15; 15(3):545-9. PubMed ID: 16465410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 77.